Scientists have found that tiny changes to a person's genetic sequence are associated with one's educational level.
There is a healthy pipeline of cell therapies coming from Asia, says Mr. Kim Raineri, Business Director at Lonza Bioscience Singapore.
A*STAR's GIS and Sengenics will partner on cancer biomarker discovery with the aim of identifying and validating auto-antibodies that can be used to detect early-stage cancers.
Agilent, the University of Rouen, and A*STAR have signed an MOU to develop tools to effectively analyze biologics and vaccines.
United Microelectronics Corporation has established the Fab 12i Center of Excellence in Singapore.
A*STAR has signed an agreement with QuantuMDx, a UK-based biotech developing handheld diagnostics and whole genome sequencing devices.
Singapore's A*STAR and Switzerland's Cytos Biotechnology AG today announced the initiation of Phase I trials for their H1N1 influenza vaccine candidate.
Lloyd's Register and A*STAR have officially opened a joint laboratory to study the challenges faced by the marine, energy, and offshore sectors.